Skip to main content
. 2021 Mar 15;35(8):910–918. doi: 10.1177/0269881121991827

Figure 2.

Figure 2.

Meta-analysis of four double-blind randomised controlled trials (RCTs) with 20–40 IU onabotulinumtoxinA.